TP53 and neoplasm: On the one hand, there are studies that found a functional p53 to promote a radiosensitizing effect of PARPis in different tumor entities [82,83], while, on the other hand, there is evidence that the loss-of-function mutations of p53 lead to increased radiosensitivity by PARPis through the activation of oxidative stress pathways [84].